Enhancing Clinical Trial Outcomes through Effective Data
Integration, Standardization and Compliance
15th February 2022
Nigel Hughes
Scientific Director Janssen
Nigel Hughes has a thirty-five-year career spanning the NHS in the UK (16 years), NGOs and patient organisations (10 years) and within the pharmaceutical industry (17 years) He has worked clinically in HIV and viral hepatitis, liver disease, and in sales & marketing, medical affairs, market access and health economics, R&D, precision medicine, advanced diagnostics, health IT and Real World Data/Real World Medicine. His experience covers clinical, education, as an advisor, consulting, communications and lobbying over the years. He is currently the Project Lead for the IMI2 European Health Data & Evidence Network (EHDEN), and was Platform Co-Lead for the IMI1 European Medical Information Framework (EMIF), as well as consulting on numerous projects and programmes in the domain of RWD/RWE.
Day One - 15th February 2022
9:00 AM Accelerating Clinical Trial Workflows with AI – Beyond the Hype, a Real-World Use Case
Join Janssen Scientific Director, Nigel Hughes, Pentavere Chief Medical Officer Dr. Christopher Pettengell for a fireside chat on the challenges surrounding clinical trial data, and how innovative collaborations between pharma and AI companies, such as Janssen’s collaboration with Pentavere, are driving efficiencies so patients can access treatment sooner. This session will address:
• Increasing complexity of clinical trial data is a key factor impacting clinical trial success, and COVID is accelerating these challenges
• Need for clinical trial data management innovation, which is often overlooked in comparison to AI applications for drug discovery
• A leading real-world use case of Janssen & Pentavere’s successful collaboration using AI to accelerate and de-risk clinical trial data management
In Partnership With :
©2024 IQPC. All rights reserved.
